Search

Search Funnelback University

Search powered by Funnelback
Your query has been expanded to `news stories` |u:www.enterprize.cam.ac.uk.  Search for `news stories` |u:www.enterprise.cam.ac.uk instead.
51 - 60 of 178 search results for `news stories` |u:www.enterprise.cam.ac.uk or `news stories` |u:www.enterprize.cam.ac.uk
  1. Fully-matching results

  2. Sustainability, investment and the Carbon Challenge – Cambridge…

    https://www.enterprise.cam.ac.uk/video/sustainability-investment-and-the-carbon-challenge/
    Thumbnail for Sustainability, investment and the Carbon Challenge – Cambridge Enterprise 12 Oct 2022: Chris Gibbs shares his perspectives on the importance of sustainability, investing in sustainability businesses and building entrepreneurial mindsets through the Carbon Challenge.
  3. KARPAS 241 Human Monoblastic cell line

    https://www.enterprise.cam.ac.uk/reagents/karpas-241-human-monoblastic-cell-line/
    Thumbnail for KARPAS 241 Human Monoblastic cell line 9 May 2022: KARPAS 241 Human Monoblastic cell line useful in oncology research, developed at the University of Cambridge.
  4. The journey of a University idea – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/for-the-university/develop-a-commercial-opportunity/the-journey-of-a-university-idea/
    10 May 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. The journey of a University idea. How to make your commercial idea thrive. You have come up with an exciting commercial idea – but what do you do next? The diagram below gives an
  5. Nyobolt: Supercharging the electric revolution – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/case-studies/nyobolt-supercharging-the-electric-revolution/
    Thumbnail for Nyobolt: Supercharging the electric revolution – Cambridge Enterprise 11 Apr 2022: Nyobolt is a University spin out from the Yusuf Hamied Department of Chemistry, commercialising a novel ultra-high power battery technology
  6. Cambridge joins $72.5m round launching mitochondrial therapies…

    https://www.enterprise.cam.ac.uk/news/cambridge-joins-72-5m-round-launching-mitochondrial-therapies-pioneer-pretzel/
    Thumbnail for Cambridge joins $72.5m round launching mitochondrial therapies pioneer Pretzel – Cambridge Enterprise 19 Sep 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. 12 September 2022. Cambridge joins $72.5m round launching mitochondrial therapies pioneer Pretzel. Share:. a biotechnology company harnessing the intricacies of mitochondrial biology to
  7. Human CD59 monoclonal antibody YTH 53.1

    https://www.enterprise.cam.ac.uk/reagents/human-cd59-monoclonal-antibody-yth-53-1/
    Thumbnail for Human CD59 monoclonal antibody YTH 53.1 9 May 2022: Hybridoma cell line producing YTH 53.1 antibodies raised against human CD59 which are rat monoclonal antibodies of the IgG2b isotype.
  8. Human CD7 monoclonal antibody YTH 30.15

    https://www.enterprise.cam.ac.uk/reagents/human-cd7-monoclonal-antibody-yth-30-15/
    Thumbnail for Human CD7 monoclonal antibody YTH 30.15 9 May 2022: Hybridoma cell line producing YTH 30.15 antibodies raised against human CD7 which are rat monoclonal antibodies of the IgG2b isotype.
  9. Case study: Futures We Want – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/case-studies/consultancy-services-determining-the-futures-we-want/
    Thumbnail for Case study: Futures We Want – Cambridge Enterprise 11 Apr 2022: Evidence included scientific papers, government reports, and local news articles. The close collaboration with local expert teams throughout the process brought great depth of knowledge, and ensured that visions remained focused
  10. Sparxell wins the 2022 Chris Abell Postdoc Business Plan Competition…

    https://www.enterprise.cam.ac.uk/news/sparxell-wins-the-2022-chris-abell-postdoc-business-plan-competition/
    Thumbnail for Sparxell wins the 2022 Chris Abell Postdoc Business Plan Competition – Cambridge Enterprise 11 Nov 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. 11 November 2022. Sparxell wins the 2022 Chris Abell Postdoc Business Plan Competition. Share:. Sparxell has won the Chris Abell Postdoc Business Plan Competition 2022, securing the £20
  11. Human CD11a monoclonal antibody YTH 81.5

    https://www.enterprise.cam.ac.uk/reagents/human-cd11a-monoclonal-antibody-yth-81-5/
    Thumbnail for Human CD11a monoclonal antibody YTH 81.5 9 May 2022: Hybridoma cell line producing YTH 81.5 antibodies raised against human CD11a which are rat monoclonal antibodies of the IgG2a isotype.

Refine your results

Search history

Recently clicked results

Recently clicked results

Your click history is empty.

Recent searches

Recent searches

Your search history is empty.